326 related articles for article (PubMed ID: 26671309)
1. A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping.
Tembhare P; Badrinath Y; Ghogale S; Patkar N; Dhole N; Dalavi P; Kunder N; Kumar A; Gujral S; Subramanian PG
Cytometry A; 2016 Mar; 89(3):281-91. PubMed ID: 26671309
[TBL] [Abstract][Full Text] [Related]
2. Method for DNA Ploidy Analysis Along with Immunophenotyping for Rare Populations in a Sample using FxCycle Violet.
Tembhare P; Badrinath Y; Ghogale S; Subramanian PG
Curr Protoc Cytom; 2017 Apr; 80():6.38.1-6.38.15. PubMed ID: 28369766
[TBL] [Abstract][Full Text] [Related]
3. Blast size-specific flowcytometric ploidy assessment using FxCycle
Bommannan K; Arumugam JR; Koshy T; Radhakrishnan V; Sagar TG; Sundersingh S
Int J Lab Hematol; 2021 Aug; 43(4):760-770. PubMed ID: 33345449
[TBL] [Abstract][Full Text] [Related]
4. FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone.
Gupta N; Parihar M; Banerjee S; Brahma S; Pawar R; Rath A; Shewale S; Singh M; Sasikumaran Nair Remani A; Krishnan S; Bhatacharyya A; Das A; Kumar J; Bhave S; Radhakrishnan V; Nair R; Chandy M; Mishra D; Arora N
Cytometry B Clin Cytom; 2019 Sep; 96(5):359-367. PubMed ID: 30715800
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
6. DRAQ5: improved flow cytometric DNA content analysis and minimal residual disease detection in childhood malignancies.
Swerts K; Van Roy N; Benoit Y; Laureys G; Philippé J
Clin Chim Acta; 2007 Apr; 379(1-2):154-7. PubMed ID: 17229416
[TBL] [Abstract][Full Text] [Related]
7. Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B-cell acute lymphoblastic leukemia using multicolor flow cytometry.
Chaturvedi A; Shetty D; Ghogale SG; Deshpande N; Badrinath Y; Chatterjee G; Girase K; Sriram H; Khanka T; Mishra C; Dasgupta N; Gujarathi SA; Rajpal S; Patkar N; Amare-Kadam P; Gujral S; Subramanian PG; Tembhare PR
Cytometry B Clin Cytom; 2022 May; 102(3):199-208. PubMed ID: 35212133
[TBL] [Abstract][Full Text] [Related]
8. Flow Cytometric DNA Ploidy Analysis in Haemato-Lymphoid Neoplasms: An Analysis of 132 Cases.
Gupta N; Mittal A; Dadu T; Choudhary D; Handoo A
Int J Hematol Oncol Stem Cell Res; 2022 Jan; 16(1):34-46. PubMed ID: 35975117
[No Abstract] [Full Text] [Related]
9. Flow cytometric DNA-quantification of three-color immunophenotyped cells for subpopulation specific determination of aneuploidy and proliferation.
Oelschlaegel U; Freund D; Range U; Ehninger G; Nowak R
J Immunol Methods; 2001 Jul; 253(1-2):145-52. PubMed ID: 11384676
[TBL] [Abstract][Full Text] [Related]
10. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection.
Weir EG; Cowan K; LeBeau P; Borowitz MJ
Leukemia; 1999 Apr; 13(4):558-67. PubMed ID: 10214862
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy analysis as an adjunct for the detection of relapse in B-lineage acute lymphoblastic leukemia.
Kenney B; Zieske A; Rinder H; Smith B
Leuk Lymphoma; 2008 Jan; 49(1):42-8. PubMed ID: 18203010
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow.
Nowak R; Oelschlaegel U; Schuler U; Zengler H; Hofmann R; Ehninger G; Andreeff M
Cytometry; 1997 Feb; 30(1):47-53. PubMed ID: 9056742
[TBL] [Abstract][Full Text] [Related]
13. High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma.
Almeida J; Orfao A; Ocqueteau M; Mateo G; Corral M; Caballero MD; Blade J; Moro MJ; Hernandez J; San Miguel JF
Br J Haematol; 1999 Oct; 107(1):121-31. PubMed ID: 10520032
[TBL] [Abstract][Full Text] [Related]
14. [Bone marrow immunophenotyping for the diagnosis of multiple myeloma: practical aspects].
Kurtova AV; Sivachenko EB; Utkina LA; Slobodniuk KIu; Stepanova NV; Iakubovich MA; Moiseev SI; Zueva EE
Klin Lab Diagn; 2008 Jan; (1):17-20. PubMed ID: 18314774
[TBL] [Abstract][Full Text] [Related]
15. A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-10
Tembhare PR; Subramanian Pg PG; Ghogale S; Chatterjee G; Patkar NV; Gupta A; Shukla R; Badrinath Y; Deshpande N; Narula G; Rodrigues P; Girase K; Dhaliwal D; Prasad M; Shetty D; Banavali S; Gujral S
Cytometry B Clin Cytom; 2020 Jan; 98(1):57-67. PubMed ID: 31197916
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
17. Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myeloma.
Morgan RJ; Gonchoroff NJ; Katzmann JA; Witzig TE; Kyle RA; Greipp PR
Am J Hematol; 1989 Apr; 30(4):195-200. PubMed ID: 2929579
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
[TBL] [Abstract][Full Text] [Related]
19. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
